Kezar Life Sciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kezar Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Kezar Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.39M, a 72.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.39M -$6.26M -72.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $4.36M -$4.84M -52.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.78M -$4.96M -51% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $8.07M +$5.88M +268% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.65M +$6.27M +264% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $9.2M +$6.66M +261% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.74M +$7.03M +259% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.19M -$682K -23.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.37M -$653K -21.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.55M -$626K -19.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.71M -$600K -18.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $2.87M -$574K -16.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.03M -$549K -15.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.17M -$526K -14.2% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $3.31M -$503K -13.2% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $3.45M -$481K -12.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.58M -$460K -11.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.7M -$440K -10.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.82M -$383K -9.12% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $3.93M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $4.04M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $4.14M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $4.2M Dec 31, 2018 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.